Medoderm Overview

  • Founded
  • 2010
  • Status
  • Private
  • Employees
  • 7
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

Medoderm General Information


Developer of pharmaceutical drugs intended to be used for wound healing and medical skincare of humans, pets, and riding animals. The company's drug is a chitosan-based healing product made from active ingredients based on nature without any disturbing ingredients, enabling patients to get treatments like wound dressing, antibiotics, coagulants, and selective growth stimulators.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Other Healthcare Services
Primary Office
  • Robert-Koch-Straße 50 D
  • 55129 Mainz
  • Germany
+49 06131 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medoderm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Startup
To view Medoderm’s complete valuation and funding history, request access »

Medoderm Executive Team (8)

Name Title Board Seat Contact Info
Manfred Beleut Chief Executive Officer
Günter Bauer Chief Technology Officer and Authorized Signatory
Philippe Henco Chief Marketing Officer
Nadine Weiner Controller
You’re viewing 4 of 8 executive team members. Get the full list »

Medoderm Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medoderm Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
HS LifeSciences Venture Capital Minority 000 0000 000000 0
To view Medoderm’s complete investors history, request access »